Align Technology (NASDAQ:ALGN) Shares Gap Up – What’s Next?

Shares of Align Technology, Inc. (NASDAQ:ALGN) gapped up before the market opened on Thursday . The stock had previously closed at $172.41, but opened at $180.00. Align Technology shares last traded at $178.6940, with a volume of 645,187 shares trading hands.

Align Technology News Roundup

Here are the key news stories impacting Align Technology this week:

• Positive Sentiment: Elliott Investment Management has built a significant/activist stake in Align, which investors expect could push for strategic actions (cost cuts, capital returns, M&A or other value-enhancing moves). Activist involvement often acts as a near-term catalyst for underperforming names. Elliott builds stake – Reuters
• Positive Sentiment: Barclays upgraded ALGN to Overweight and set a higher price target, citing improved valuation after the stock’s pullback — that fresh analyst support can attract buyers and institutional flows. Barclays upgrade – Seeking Alpha
• Neutral Sentiment: Align’s strategic partnerships and product positioning in digital dentistry (e.g., involvement in SprintRay’s “Midas” education program) support the company’s long-term TAM and stickiness of iTero scanners, but these are longer-term fundamentals rather than immediate catalysts. SprintRay collaboration – Yahoo
• Neutral Sentiment: Several outlets and aggregators are highlighting rising momentum indicators and institutional interest; these technical/flow signals can reinforce the move but don’t change underlying fundamentals. (Multiple press/quote sources consolidated).
• Negative Sentiment: Underlying revenue growth has slowed from pandemic-era peaks as cosmetic demand normalized; that’s the root reason Elliott is likely pressing for changes — an operational headwind that could constrain upside absent successful execution of new initiatives. Weaker demand context – Benzinga

Wall Street Analysts Forecast Growth

ALGN has been the subject of a number of recent analyst reports. Robert W. Baird set a $218.00 price target on shares of Align Technology in a research note on Thursday, February 5th. Stifel Nicolaus raised their price objective on shares of Align Technology from $200.00 to $210.00 and gave the stock a “buy” rating in a research note on Thursday, February 5th. Morgan Stanley upped their target price on Align Technology from $154.00 to $169.00 and gave the company an “equal weight” rating in a research note on Thursday, February 5th. Wall Street Zen upgraded Align Technology from a “buy” rating to a “strong-buy” rating in a report on Saturday, March 7th. Finally, Weiss Ratings raised Align Technology from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, January 16th. Seven equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat.com, Align Technology currently has a consensus rating of “Moderate Buy” and a consensus target price of $198.08.

Align Technology Trading Up 3.2%

The company has a market capitalization of $12.68 billion, a PE ratio of 31.47, a PEG ratio of 1.92 and a beta of 1.79. The firm’s 50-day simple moving average is $176.43 and its 200-day simple moving average is $153.90.

Align Technology (NASDAQ:ALGN) last posted its quarterly earnings results on Wednesday, February 4th. The medical equipment provider reported $3.29 earnings per share for the quarter, beating the consensus estimate of $2.99 by $0.30. Align Technology had a net margin of 10.17% and a return on equity of 15.16%. The firm had revenue of $1.05 billion during the quarter, compared to the consensus estimate of $1.03 billion. During the same quarter in the previous year, the firm posted $2.44 earnings per share. The company’s revenue was up 5.3% on a year-over-year basis. As a group, analysts anticipate that Align Technology, Inc. will post 7.98 EPS for the current year.

Insider Activity

In other news, EVP John Morici sold 7,969 shares of the firm’s stock in a transaction on Wednesday, February 18th. The stock was sold at an average price of $189.31, for a total transaction of $1,508,611.39. Following the transaction, the executive vice president owned 8,237 shares in the company, valued at approximately $1,559,346.47. This trade represents a 49.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 0.66% of the company’s stock.

Institutional Trading of Align Technology

A number of hedge funds have recently added to or reduced their stakes in ALGN. Sentry Investment Management LLC lifted its position in shares of Align Technology by 73.1% in the 3rd quarter. Sentry Investment Management LLC now owns 187 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 79 shares during the period. Sunbelt Securities Inc. raised its stake in Align Technology by 222.4% in the fourth quarter. Sunbelt Securities Inc. now owns 158 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 109 shares in the last quarter. Steigerwald Gordon & Koch Inc. purchased a new stake in Align Technology during the third quarter worth $26,000. Rothschild Investment LLC boosted its position in Align Technology by 140.3% during the 2nd quarter. Rothschild Investment LLC now owns 149 shares of the medical equipment provider’s stock valued at $28,000 after acquiring an additional 87 shares in the last quarter. Finally, Independence Bank of Kentucky boosted its position in Align Technology by 77.7% during the 4th quarter. Independence Bank of Kentucky now owns 183 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 80 shares in the last quarter. 88.43% of the stock is owned by hedge funds and other institutional investors.

Align Technology Company Profile

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.